Drug Shortage Report for PMS-NAPROXEN EC

Last updated on 2020-06-10 History
Report ID 6145
Drug Identification Number 02294710
Brand name PMS-NAPROXEN EC
Common or Proper name NAPROZEN
Company Name PHARMASCIENCE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-01
Actual start date 2017-12-15
Estimated end date Unknown
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments Product to be discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-06-10 French Compare
v14 2020-06-10 English Compare
v13 2017-12-18 French Compare
v12 2017-12-18 English Compare
v11 2017-12-02 English Compare
v10 2017-10-11 French Compare
v9 2017-10-11 English Compare
v8 2017-09-29 English Compare
v7 2017-05-12 French Compare
v6 2017-05-12 English Compare
v5 2017-05-02 French Compare
v4 2017-05-02 English Compare
v3 2017-04-08 English Compare
v2 2017-04-07 French Compare
v1 2017-04-07 English Compare

Showing 1 to 15 of 15